Page last updated: 2024-08-23

daunorubicin and Colorectal Neoplasms

daunorubicin has been researched along with Colorectal Neoplasms in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's2 (18.18)18.2507
2000's5 (45.45)29.6817
2010's2 (18.18)24.3611
2020's1 (9.09)2.80

Authors

AuthorsStudies
Fossati, G; Kapuvári, B; Mező, G; Ranđelović, I; Schuster, S; Steinkühler, C; Tóvári, J1
Büküm, N; Danielisová, P; Milan, J; Morell, A; Novotná, E; Wsól, V1
Gacs, A; Hegedüs, R; Kapuvári, B; Manea, M; Mező, G; Schulcz, Á; Tóvári, J; Vincze, B1
Bosch, SV; de Jonge, MJ; Fiorentini, F; Hess, D; Lechuga, MJ; Mantel, MA; Mora, O; Planting, AS; Sessa, C; Valota, O; van der Gaast, A; Verweij, J1
Chiam, AS; Huxham, LA; Kyle, AH; Minchinton, AI; Sim, DH1
Benoît, V; Bours, V; Chariot, A; Deregowski, V; Greimers, R; Jacobs, N; Lechanteur, C; Merville, MP1
Gassner, B; Gekle, M; Kelleher, DK; Lotz, C; Thews, O; Vaupel, P1
Codacci-Pisanelli, D; Franchi, F; Konovalova, NP; Seminara, P; Volkova, LM1
Franchi, F; Giannarelli, D; Konovalova, N; Seminara, P1
Dimitrov, V; Dudunkov, Z; Kurtev, P; Kurteva, G; Ralchev, K1
Decoster, G; Holdener, EE; Ludwig, C; Pinedo, HM; Renard, G; ten Bokkel Huinink, WW1

Trials

2 trial(s) available for daunorubicin and Colorectal Neoplasms

ArticleYear
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours.
    European journal of cancer (Oxford, England : 1990), 2002, Volume: 38, Issue:18

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Daunorubicin; Dose-Response Relationship, Drug; Drug Hypersensitivity; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasms; Vomiting

2002
Phase II trial of menogaril in advanced colorectal cancer.
    Investigational new drugs, 1988, Volume: 6, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Tests; Humans; Male; Menogaril; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nogalamycin

1988

Other Studies

9 other study(ies) available for daunorubicin and Colorectal Neoplasms

ArticleYear
Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.
    International journal of molecular sciences, 2019, Sep-25, Volume: 20, Issue:19

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Daunorubicin; Disease Models, Animal; Female; Gene Expression; Gonadotropin-Releasing Hormone; Humans; Male; Mice; Molecular Structure; Pyrrolidonecarboxylic Acid; Receptors, Cell Surface; RNA, Messenger; Toxicity Tests; Xenograft Model Antitumor Assays

2019
Selective inhibition of aldo-keto reductase 1C3: a novel mechanism involved in midostaurin and daunorubicin synergism.
    Archives of toxicology, 2021, Volume: 95, Issue:1

    Topics: Aldo-Keto Reductase Family 1 Member C3; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Colorectal Neoplasms; Daunorubicin; Drug Synergism; Enzyme Inhibitors; fms-Like Tyrosine Kinase 3; HCT116 Cells; Humans; Leukemia, Myeloid, Acute; Staurosporine

2021
Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.
    Investigational new drugs, 2016, Volume: 34, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Butyric Acid; Cell Proliferation; Colorectal Neoplasms; Daunorubicin; Female; Gonadotropin-Releasing Hormone; Heart; HT29 Cells; Humans; Liver; Male; Mice; Neovascularization, Pathologic; Pyrrolidonecarboxylic Acid; Tumor Burden; Xenograft Model Antitumor Assays

2016
Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture.
    Cancer research, 2004, Sep-01, Volume: 64, Issue:17

    Topics: Anthracyclines; Antibiotics, Antineoplastic; Colorectal Neoplasms; Daunorubicin; Doxorubicin; Epirubicin; HCT116 Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Mitoxantrone; Spectrometry, Fluorescence; Tumor Cells, Cultured

2004
Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis.
    Oncogene, 2005, Mar-03, Volume: 24, Issue:10

    Topics: Apoptosis; Cell Cycle Proteins; Cell Hypoxia; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cytoprotection; Daunorubicin; HCT116 Cells; Humans; Phosphatidylinositol 3-Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tumor Suppressor Protein p53

2005
Role of the tumor microenvironment in the activity and expression of the p-glycoprotein in human colon carcinoma cells.
    Oncology reports, 2007, Volume: 17, Issue:1

    Topics: Acidosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Hypoxia; Cell Line, Tumor; Colorectal Neoplasms; Daunorubicin; Humans; Hydrogen-Ion Concentration

2007
[Effect of Ruboxyl (nitroxyl derivative of daunorubicin) on hepatic metastases of colorectal carcinoma].
    Voprosy onkologii, 2000, Volume: 46, Issue:4

    Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Colorectal Neoplasms; Daunorubicin; Fluorouracil; Infusions, Intravenous; Liver Neoplasms; Mice; Rats

2000
Fractional incorporation of radionucleotides, a marker of in vitro tumor cell chemosensitivity in colorectal cancer.
    Oncology, 1991, Volume: 48, Issue:6

    Topics: Antineoplastic Agents; Colorectal Neoplasms; Daunorubicin; DNA, Neoplasm; Doxorubicin; Humans; In Vitro Techniques; Liver Neoplasms; Mitomycin; RNA, Neoplasm; Thymidine; Tritium; Tumor Cells, Cultured; Uridine

1991
[A combined method for treating metastases of colorectal carcinoma to the liver].
    Khirurgiia, 1991, Volume: 44, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Colorectal Neoplasms; Combined Modality Therapy; Daunorubicin; Fluorouracil; Hepatectomy; Humans; Liver Neoplasms; Mitomycins

1991